Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aziyo Biologics Inc.

    NASDAQ: AZYO · Real-Time Price · USD
    1.49
    0.03 (2.05%)
    At close: Sep 06, 2023, 9:59 PM

    Aziyo Biologics Statistics

    Share Statistics

    Aziyo Biologics has 16.25M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 16.25M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 4.12M

    Failed to Deliver (FTD) Shares

    n/a
    		 4,669

    FTD / Avg. Volume

    n/a
    		 1.08%

    Short Selling Information

    The latest short interest is 62.67K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 62.67K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 1.04%

    Short Ratio (days to cover)

    n/a
    		 5.26

    Valuation Ratios

    The PE ratio is -0.75 and the forward PE ratio is null. Aziyo Biologics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.75

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 1.66

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -0.87

    P/FCF Ratio

    n/a
    		 -1.78

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Aziyo Biologics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.69, with a Debt / Equity ratio of -0.65.

    Current Ratio

    n/a
    		 0.69

    Quick Ratio

    n/a
    		 0.59

    Debt / Equity

    n/a
    		 -0.65

    Debt / EBITDA

    n/a
    		 -0.85

    Debt / FCF

    n/a
    		 -1.33

    Interest Coverage

    n/a
    		 -7.46

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $161,423.84

    Profits Per Employee

    n/a
    		 $-357,278.15

    Employee Count

    n/a
    		 151

    Asset Turnover

    n/a
    		 0.67

    Inventory Turnover

    n/a
    		 3.49

    Taxes

    Income Tax

    n/a
    		 7K

    Effective Tax Rate

    n/a
    		 -0.01%

    Stock Price Statistics

    The stock price has increased by 7.19% in the last 52 weeks. The beta is -0.08, so Aziyo Biologics's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.08

    52-Week Price Change

    n/a
    		 7.19%

    50-Day Moving Average

    n/a
    		 1.55

    200-Day Moving Average

    n/a
    		 2.62

    Relative Strength Index (RSI)

    n/a
    		 48.31

    Average Volume (20 Days)

    n/a
    		 432,734

    Income Statement

    In the last 12 months, Aziyo Biologics had revenue of 24.38M and earned -53.95M in profits. Earnings per share was -1.86.

    Revenue

    n/a
    		 24.38M

    Gross Profit

    n/a
    		 10.71M

    Operating Income

    n/a
    		 -35.65M

    Net Income

    n/a
    		 -53.95M

    EBITDA

    n/a
    		 -35.65M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -1.86
    Full Income Statement

    Balance Sheet

    The company has 13.24M in cash and 30.23M in debt, giving a net cash position of -16.99M.

    Cash & Cash Equivalents

    n/a
    		 13.24M

    Total Debt

    n/a
    		 30.23M

    Net Cash

    n/a
    		 -16.99M

    Retained Earnings

    n/a
    		 -229.59M

    Total Assets

    n/a
    		 39.3M

    Working Capital

    n/a
    		 -6.83M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -22.66M and capital expenditures 0, giving a free cash flow of -22.66M.

    Operating Cash Flow

    n/a
    		 -22.66M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -22.66M

    FCF Per Share

    n/a
    		 -0.78
    Full Cash Flow Statement

    Margins

    Gross margin is 43.93%, with operating and profit margins of -146.26% and -221.33%.

    Gross Margin

    n/a
    		 43.93%

    Operating Margin

    n/a
    		 -146.26%

    Pretax Margin

    n/a
    		 -222.04%

    Profit Margin

    n/a
    		 -221.33%

    EBITDA Margin

    n/a
    		 -146.26%

    EBIT Margin

    n/a
    		 -146.26%

    FCF Margin

    n/a
    		 -92.95%

    Dividends & Yields

    AZYO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for AZYO.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -12.37

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist